Our governance
The main decision-making, executive and managerial bodies at the Medicines and Healthcare products Regulatory Agency (MHRA).
Corporate governance
We鈥檙e governed by a unitary agency board with an equal number of executive and non-executive directors, and non-executive chair, supported by three board assurance committees.
The board
The unitary board is responsible for advising on the strategic direction of the agency, ensuring that targets set out in the business plan and agreed with ministers, are met.
The board supports the Chief Executive in the effective delivery of services and overall performance by providing leadership, developing strategy, advising on the delivery of policies, maintaining high standards of corporate governance, scrutinising performance and ensuring that controls are in place to manage risk.
The board does not have involvement in any regulatory decisions affecting medicines or medical devices. These are the responsibility of the Chief Executive and Executive Committee.
Members
The unitary board has an equal number of non-executive and executive directors.
- Professor Anthony Harnden (Chair)
- Lawrence Tallon (Chief Executive)
- Amanda Calvert (Non-Executive Director)
- Dr Junaid Bajwa (Non-Executive Director)
- Professor Graham Cooke (Non-Executive Director)
- Dr Paul Goldsmith (Non-Executive Director)
- Haider Husain (Non-Executive Director)
- Mercy Jeyasingham MBE (Non-Executive Director)
- Raj Long (Non-Executive Director)
- Michael Whitehouse OBE (Non-Executive Director)
- Julian Beach聽(Interim Executive Director of Healthcare Quality and Access)
- Liz Booth聽(Chief People Officer)
- Rose Braithwaite聽(Chief Finance Officer)
- Alison Cave (Chief Safety Officer)
- Claire Harrison (Chief Digital and Technology Officer)
- Dr Nicola Rose聽(Interim Executive Director of Science and Research)
Board members鈥� declarations of interest
MHRA Board terms of reference
MHRA Board meetings in 2025
Our next MHRA Board Meeting held in public will be conducted virtually by webinar on Tuesday 18 March聽from 10:00am until 12:30pm (GMT). This meeting is now open for public registrations. Book your place: .
MHRA Board minutes
Older minutes are available on .
Previous Board meetings and public sessions
MHRA Board meeting held on 18 March 2025
MHRA Board meeting held on 17 September 2024
MHRA Board meeting held on 9 July 2024
MHRA Board meeting held in public on 21 May 2024
MHRA Board meeting held in public on 19 March 2024
MHRA Board meeting held in public on 16 January 2024
MHRA Board meeting held in public on 21 November 2023
MHRA Board meeting held in public on 19 September 2023
MHRA Board meeting held in public on 11 July 2023
MHRA Board meeting held in public on 16 May 2023
MHRA Board meeting held in public on 21 March 2023
MHRA Board meeting held in public on 17 January 2023
MHRA Board meeting held in public on 15 November 2022
MHRA Board meeting held in public on 20 September 2022
MHRA Board meeting held in public on 21 June 2022
MHRA Board meeting held in public on 19 April 2022
MHRA Board meeting held in public on 15 February 2022
Papers for the MHRA Board meeting held in public on 18 January 2022
Papers for the MHRA Board meeting held in public on 16 November 2021
Papers for the MHRA Board meeting held in public on 19 October 2021
Papers for the MHRA Board meeting held in public on 21 September 2021
Papers for the MHRA Board meeting held in public on 20 July 2021
Papers for the MHRA Board meeting held in public on 15 June 2021
Papers for the MHRA Board meeting held in public on 18 May 2021
Papers for the MHRA Board meeting held in public on 20 April 2021
Papers for the MHRA Board meeting held in public on 16 March 2021
Papers for the MHRA Board meeting held in public on 16 February 2021
Agenda and papers
Papers for the MHRA Board meeting held in public on 19 January 2021
Agenda and papers
Papers for the MHRA Board meeting held in public on 23 November 2020
Agenda and papers
Papers for the MHRA Board meeting held in public on 26 October 2020
Agenda and papers
Executive Committee
The Executive Committee is the highest executive decision-making body of the agency and is chaired by the Chief Executive Lawrence Tallon. The Executive Committee ensures that the decisions which are critical to the agency are taken in a timely way, at the right level in the organisation, by the right people with the right evidence. This ensures clear accountability for delivery, strong management of risk, transparent priorities and that business is conducted in a smooth and predictable fashion. It is comprised of:
- Lawrence Tallon (Chief Executive)
- Alison Cave (Chief Safety Officer)
- Carly McGurry (Director of Governance)
- Claire Harrison (Chief Digital and Technology Officer)
- Harriet Teare (Interim Director of Partnerships)
- James Pound (Interim Executive Director of Innovation and Compliance)
- Julian Beach (Interim Executive Director of Healthcare Quality and Access)
- Liz Booth (Chief People Officer)
- Nicola Rose (Interim Executive Director of Science and Research)
- Rachel Arrundale (Interim Director of Partnerships)
- Rachel Bosworth (Director of Communications and Engagement)
- Rose Braithwaite (Chief Finance Officer)